SCHEMBL6444130

SCHEMBL6444130

CC(=O)OC(=O)c1ccc(Cl)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.52
CES2 O00748 3/20 0.50
CES1 P23141 3/20 0.50
KMT2A Q03164 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
MEN1 O00255 3/20 0.49
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48
HPGD P15428 1/20 0.47
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 3/20 0.45
NPSR1 Q6W5P4 1/20 0.45
HTT P42858 1/20 0.44
NLRP1 Q9C000 1/20 0.44
SRD5A2 P31213 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL123279 0.89 TSHR (0.47) ALDH1A1KMT2ASMN1; SMN2MEN1RAB9A
SCHEMBL28775846 0.86 CES2 (0.59) ALDH1A1CES2CES1KMT2ASMN1; SMN2
SCHEMBL247590 0.86 CES2 (0.59) ALDH1A1CES2CES1KMT2ASMN1; SMN2
SCHEMBL8923096 0.83 ALDH1A1 (0.49) ALDH1A1CES2CES1KMT2ASMN1; SMN2
SCHEMBL8798021 0.83 ALDH1A1 (0.49) ALDH1A1CES2CES1KMT2ASMN1; SMN2
SCHEMBL11762738 0.82 MAOB (0.73) ALDH1A1KMT2ASMN1; SMN2MEN1NPC1
SCHEMBL4493359 0.82 MAPT (0.54) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL18050295 0.80 CES2 (0.52) ALDH1A1CES2CES1KMT2ASMN1; SMN2
SCHEMBL18050293 0.80 CES2 (0.52) ALDH1A1CES2CES1KMT2ASMN1; SMN2
SCHEMBL8030701 0.80 CA12 (0.61) ALDH1A1KMT2ASMN1; SMN2MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114685298-B Method for synthesizing baclofen based on photocatalytic migration strategy 兰州大学 2023-10-24 CN claimed
CN-114685298-A Method for synthesizing baclofen based on photocatalytic migration strategy 兰州大学 2022-07-01 CN claimed
US-20050153404-A1 Anti-kazlauskas lipases LANXESS DEUTSCHLAND GMBH (DE) 2005-07-14 US claimed
CN-114685298-B Method for synthesizing baclofen based on photocatalytic migration strategy 兰州大学 2023-10-24 CN disclosed
CN-114685298-B Method for synthesizing baclofen based on photocatalytic migration strategy 兰州大学 2023-10-24 CN disclosed
CN-114685298-A Method for synthesizing baclofen based on photocatalytic migration strategy 兰州大学 2022-07-01 CN disclosed
CN-114685298-A Method for synthesizing baclofen based on photocatalytic migration strategy 兰州大学 2022-07-01 CN disclosed
CN-108929226-B Method for preparing benzoyl formate derivative 广东工业大学 2021-05-28 CN disclosed
CN-111393291-A Novel synthesis method of α -carbonyl acid ester 宁波海曙琼杰化工技术研发工作室 2020-07-10 CN disclosed
EP-1215216-B1 Cellulose ester of aromatic carboxylic acid FUJI PHOTO FILM CO LTD (JP) 2005-07-27 EP disclosed
US-20050153404-A1 Anti-kazlauskas lipases LANXESS DEUTSCHLAND GMBH (DE) 2005-07-14 US disclosed
EP-1215216-A1 Cellulose ester of aromatic carboxylic acid FUJI PHOTO FILM CO., LTD. (JP) 2002-06-19 EP disclosed
US-4964896-A GAMETOCIDES MONSANTO COMPANY (US) 1990-10-23 US disclosed
US-4936904-A Aryl-4-oxonicotinates useful for inducing male sterility in cereal grain plants MONSANTO TECHNOLOGY LLC 1990-06-26 US disclosed
US-4714492-A HYBRIDIZATION AGENTS ROHM AND HAAS COMPANY (US) 1987-12-22 US disclosed
US-3932182-A An organic photoconductive composition comprising an organic photoconductive compound and a sensitizing compound having an active methylene group MITSUBISHI PAPER MILLS, LTD. (JA) 1976-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050153404-A1 Anti-kazlauskas lipases CEL, LIPA, LPL ALDH1A1 735/4885CES2 22/4885CES1 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.